Mc. Truss et al., INTRACAVERNOUS CALCITONIN-GENE-RELATED PEPTIDE PLUS PROSTAGLANDIN E(1) - POSSIBLE ALTERNATIVE TO PENILE IMPLANTS IN SELECTED PATIENTS, European urology, 26(1), 1994, pp. 40-45
The implantation of a penile prosthesis is still the ultima ratio for
patients with erectile dysfunction who fail other treatment options su
ch as pharmacotherapy and penile venous surgery. Despite mostly favora
ble results regarding restauration of erectile capacity, penile allogr
afts are often not accepted for various reasons. Therefore, pharmacote
sting with a mixture of calcitonin gene-related peptide and prostaglan
din E(1) (CGRP/PGE(1)) was offered to different selected patients popu
lations: 28 patients with erectile dysfunction and venous leakage who
failed penile venous surgery, 28 patients with erectile dysfunction an
d venous leakage (who refused penile venous surgery) and 12 patients w
ithout venous leakage, but poor response to maximum doses of papaverin
e/phentolamine, received 5 mu g CGRP plus 10 mu g PGE(1). Erections su
fficient for intercourse were noted in 19/28 (67.9%), 20/28 (71.4%) an
d 11/12 (91.7%) patients, respectively. Our data show that a combinati
on of CGRP and PGE(1) may be an alternative to penile implants in sele
cted patients.